524748 — Link Pharmachem Cashflow Statement
0.000.00%
- IN₹119.90m
- IN₹186.60m
- IN₹274.32m
Annual cashflow statement for Link Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 26.2 | 8.86 | -19.2 | -14 | 1.35 |
| Depreciation | |||||
| Non-Cash Items | 0.04 | 13.2 | 2.91 | 5.86 | 7.64 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -48 | -48.4 | 5.63 | 25.6 | 2.67 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -12.5 | -17.1 | -0.279 | 26.9 | 21.5 |
| Capital Expenditures | -11.6 | -8.93 | -9.5 | -2.57 | -21 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -38.2 | 8.18 | 13.6 | 17.9 | -5.57 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -49.8 | -0.75 | 4.05 | 15.3 | -26.6 |
| Financing Cash Flow Items | -4.51 | -7.61 | -8.72 | -7.75 | -5.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 22.7 | 16.1 | -4.07 | -42.1 | 9.92 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -39.5 | -1.74 | -0.297 | 0.003 | 4.81 |